Osteopontin is associated with bioprosthetic heart valve calcification in humans

Comptes Rendus de l'Academie des Sciences - Serie III

Volumn 320, Issue 1, 1997, Pages 49-57

  Shen, Ming ^a   Marie, Pierre ^b   Farge, Dominique ^a   Carpentier, Sophie ^a   De Pollak, Cindy ^b   Hott, Monique ^b   Chen, Lin ^a   Martinet, Bernard ^a   Carpentier, Alain ^a  

^a SORBONNE UNIVERSITÉ   (France)

^b HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Calcification; Glutaraldehyde; Osteopontin; Valvular bioprosthesis

Indexed keywords

CALCIUM BINDING PROTEIN; GLUTARALDEHYDE; HYDROXYAPATITE; OSTEOCALCIN; OSTEONECTIN; OSTEOPONTIN; POLYCLONAL ANTIBODY; SIALOPROTEIN;

ADULT; AGED; AORTA VALVE; ARTICLE; CALCIFICATION; CLINICAL ARTICLE; CONNECTIVE TISSUE; CONTROLLED STUDY; HEART VALVE BIOPROSTHESIS; HUMAN; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MICRORADIOGRAPHY; MITRAL VALVE; PROTEIN AGGREGATION; STAINING;

EID: 0030937408     PISSN: 07644469     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0764-4469(99)80086-9     Document Type: Article

References (42)

1. Carpentier A., Lemaigre G., Robert L., Carpentier S., Dubost C. 1969. Biological factors affecting long-term results of valvular heterografts. J. Thorac. Cardiovasc. Surg. 58, 467-483
2. Carpentier A., Dubost C. 1972. From xenograft to bioprosthesis: evolution of concepts and techniques of valvular xenografts. In: Biological Tissue in Heart Valve Replacement (Ionescu M.I., Ross D.N., Wooler G.H., eds), Butterworths Publ, London, 515-542
3. Maglligan D.J., Lewis J.W., Tilley B., Peterson E. 1985. The porcine bioprosthetic valve: twelve years later. J. Thorac. Cardiovasc. Surg. 89, 499-507
4. Silver M.M., Pollock J., Silver M.D., Williams WG., Trusler G.A. 1980. Calcification in porcine xenograft valves in children. Am. J. Cardiol. 45, 685-689
5. Schoen F.J., Harasaki H., Kim K.M., Andreson H.C., Levy R.J. 1988. Biomaterial-associated calcification: pathology, mechanisms, and strategies for prevention. J. Biomed. Mater. Res. 22, 11-36
6. Fishbein M.C., Levy R.J., Ferrans V.J., Dearden L.C., Nashef A., Goodman A.P., Carpentier A. 1982. Calcification of cardiac valve bioprostheses: biochemical, histologic, and ultrastructural observations in a subcutaneous implantation model system, J. Thorac. Cardiovasc. Surg. 83, 602-609
7. Gehron Robey P. 1989. The biochemistry of bone. Endocrinol. Metab. Clin. North. Am. 18, 858-902
8. Boskey A.L. 1989. Noncollagenous matrix proteins and their role in mineralization. J. Bone. Miner. Res. 6, 111-123
9. Gehron Robey P., Bianco P., Termine J.D. 1992. The cellular biology and molecular biochemistry of bone formation. In: Disorders of Bone and Mineral Metabolism (Coe F.L., Favus M.J., eds). Raven Press, New York, 241-263
10. Giachelli C.M., Bae N., Almeida M., Denhardt D.T., Alpers C.E., Schwartz S.M. 1993. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J. Clin. Invest. 2, 1686-1696
11. Fitzpatrick L.A., Severson A., Edwards W.D., Ingram R.T. 1994. Diffuse calcification in human coronary arteries. Association of osteopontin with atherosclerosis. J. Clin. Invest. 94, 1597-1604
12. Giachelli C.M., Schwartz S.M., Liaw L. 1995. Molecular and cellular biology of osteopontin. Potential role in cardiovascular disease. Trends Cardiovasc. Med. 5, 88-95
13. Murry C.E., Giachelli C.M., Schwartz S.M., Vracko R. 1994. Macrophages express osteopontin during repair of myocardial necrosis. Am. J. Pathol. 145, 1450-1462
14. O'Brien K.D., Kuusisto J., Reichenbach D.D., Ferguson M., Giachelli C., Alpers C.E., Otto C.M. 1995. Osteopontin is expressed in human aortic valvular lesions. Circulation 92, 2163-2168
15. Hott M., Marie P.J. 1987. Glycol methacrylate as an embedding medium for bone tissue. Stain Technology 62, 51-57
16. Reichert T., Störkel S., Becker K., Fischer L.W. 1992. The role of osteonectin in human tooth development: an immunohistological study. Calcif. Tissue Int. 50, 468-472
17. De Vries I.G., Coomans D., Wisse E. 1988. Immunocytochemical localization of osteocalcin in human and bovine teeth. Calcif. Tissue Int. 43, 128-130
18. Bianca P., Fisher LW., Young M.F., Termine J.D., Gehron Robey P. 1991. Expression of bone sialoprotein (BSP) in developing human tissues. Calcif. Tissue Int. 49, 421-426
19. Ingram R., Clarke B., Fisher L., Fitzpatrick L.A. 1993. Distribution of noncollagenous matrix proteins in the extracellular matrix of adult human bone: evidence of anatomical and functional heterogeneity. J. Bone Miner. Res. 8, 1019-1029
20. De Pollak C., Arnaud E., Renier D., Marie P.J. 1996. Age-related changes in bone formation, osteoblastic cell proliferation, and differentiation during postnatal osteogenesis in human. J. Cell Biochem. 63, 1-12
21. Peterson G.L. 1977. A simplification of the protein assay method of Lowry et al which is more generally applicable. Anal. Biochem. 83, 346-356
22. Laemmli U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature Lond 227, 680-685
23. Towbin H., Staehelin T., Gordon J. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some application. Proc. Natl. Acad. Sci. USA 76, 4350-4354
24. Schoen F.J. 1987. Biomaterial-associated infection, neoplasia, and calcification. Clinicopathologic features and pathophysiologic concepts. Trans. Am. Soc. Artif. Intern. Organs. 33, 8-18
25. Schoen F.J., Levy R.J., Nelson A.C., Bernhard W.F., Nasef A., Hawley M. 1985. Onset and progression of experimental bioprosthetic heart valve calcification. Lab. Invest. 52, 523-532
26. Fishbein M.C., Gissen S.A., Collins J.J. Jr., Barsamian E.M., Cohn L.H. 1977. Pathologic findings after cardiac valve replacement with glutaraldehyde-fixed porcine valves. Am. J. Cardiol. 40, 331-337
27. Levy R.J., Schoen F.J., Levy J.T., Nelson A.C., Howard S.L., Oshry L.J. 1983. Biologic determinants of dystrophic calcification and osteocalcin deposition in glutaraldehyde-preserved porcine aortic valve leaflets implanted subcutaneously in rats. Am. J. Pathol. 113, 143-155
28. Levy R.J., Zenker J.A., Lian J.B. 1980. Vitamin K-dependent calcium binding proteins in aortic valve calcification. J. Clin. Invest. 65, 563-566
29. Shen M., Farge D., Daudon M., Carpentier S., Pellerin M., Lacour B., Chen L., Martinet B., Carpentier A. 1996. Proteins and bioprosthetic calcification in the rat model. J. Heart Valve Dis. 5, 50-57
30. Mannschott P., Herbage D., Weiss M., Buffevant C. 1976. Collagen heterogeneity in pig heart valves. Biochem. Biophys. Acta 434, 177-183
31. Golomb G., Schoen F.J., Smith M.S., Linden J., Dixon M., Levy R.J. 1987. The role of glutaraldehyde-induced cross-links in calcification of bovine pericardium used in cardiac valve bioprostheses. Am. J. Pathol. 127, 122-130
32. Hauschka P.V., Lian J.B., Gallop P.M. 1975. Direct identification of the calcium-binding amino acid, γ-carboxyglutamate, in mineralized tissue. Proc. Natl. Acad. Sci. USA 72, 3925-3929
33. Sodek J., Chen J., Kasugai S., Nagata T., Zhang Q., McKee M.D., Nanci A. 1992. Elucidating the functions of bone sialoprotein and osteopontin in bone formation. In: Chemistry and Biology of Bineralized Tissues (Slavkin H., Price P., eds), Elsevier, New York, 297-306
34. Termine J.D., Kleinman H.K., Whitson S.W., Conn K.M., McGarvey M.L., Martin G.R. 1981. Osteonectin, a bone-specific protein linking mineral to collagen. Cell 26, 99-105
35. Butler W.T. 1989. The nature and significance of osteopontin. Conn. Tiss. Res. 23, 123-136
36. Mark M.P., Butler T.W., Price C.W., Finkelman R.D., Ruch J.V. 1988. Developmental expression of 44-kDa bone phosphoprotein (osteopontin) and bone γ-carboxyglutamic acid (gla)-containing protein (osteocalcin) in calcifying tissues of rat. Differentiation 37, 123-136
37. 2HS-glycoprotein) proteins in rat bone. J. Bone Miner. Res. 8, 485-496
38. Nagata T., Todescan R., Goldberg H.A., Zhang Q., Sodek J. 1989. Sulphation of secreted phosphoprotein I (SPPI, osteopontin) is associated with mineralized tissue formation. Biochem. Biophys. Res. Commun. 165, 234-240
39. Nagata T., Bellows C.G., Kasugai S., Butler W.T., Sodek J. 1991. Biosynthesis of bone proteins (SPP-1 (secreted phosphoprotein-1, osteopontin), BSP (bone sialoprotein) and SPARC (osteonectin)) in association with mineralized-tissue formation by fetal-rat calvarial cells in culture. Biochem. J. 274, 513-520
40. Nomura S., Wills A.J., Edwards D.R., Heath J.K., Hogan B.L.M. 1988. Developmental expression of 2ar (osteopontin) and SPARC (osteonectin) RNA as revealed by in situ hybridization. J. Cell Biol. 106, 441-450
41. Hirota S., Imakita M., Kohri K., Ito A., Morii E., Adachi S., Kim H.M., Kitamura Y., Yutani C., Nomura S. 1993. Expression of osteopontin messenger RNA by macrophages in atherosclerotic plaques. A possible association with calcification. Am. J. Pathol. 143, 1003-1008
42. Shanahan C.M., Cart N.R.B., Metcalfe J.C., Weissberg P.L. 1994. High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. J. Clin. Invest. 93, 2393-2402